You are here

Research

A Covid-19 Vaccine for Children May Not Arrive Before Fall 2021

The pandemic has many parents asking two burning questions. First, when can I get a vaccine? And second, when can my kids get it? It may come as a surprise that the answers are not the same. Adults may be able to get a vaccine by next summer. But their kids will have to wait longer. Perhaps a lot longer.

Thanks to the U.S. government’s Operation Warp Speed and other programs, a number of Covid-19 vaccines for adults are already in advanced clinical trials. But no trials have yet begun in the United States to determine whether these vaccines are safe and effective for children.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Does Wearing Glasses Protect You From Coronavirus?

When researchers in China were analyzing hospital data of patients with Covid-19, they noticed an odd trend: Very few of the sick patients regularly wore glasses.

In one hospital in Suizhou, China, 276 patients were admitted over a 47 day period, but only 16 patients — less than 6 percent — had myopia or nearsightedness that required them to wear glasses for more than eight hours a day. By comparison, more than 30 percent of similarly aged people in the region needed glasses for nearsightedness, earlier research had shown.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

AstraZeneca, Under Fire for Vaccine Safety, Released Trial Blueprints

AstraZeneca revealed details of its large coronavirus vaccine trials on Saturday, the third in a wave of rare disclosures by drug companies under pressure to be more transparent about how they are testing products that are the world’s best hope for ending the pandemic.

Polls are finding Americans increasingly wary of accepting a coronavirus vaccine. And scientists inside and outside the government are worried that regulators, pressured by the president for results before Election Day on Nov. 3, might release an unproven or unsafe vaccine.

Problem, Solution, SitRep, or ?: 

Drug shows promise in 1st largely minority COVID-19 study

A drug company said Friday that a medicine it sells to tamp down inflammation has helped prevent the need for breathing machines in hospitalized COVID-19 patients in the first large study that primarily enrolled Hispanics and Blacks.

Meeting / Event Tags: 
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

UPDATE: Moderna and Pfizer Reveal Secret Blueprints for Coronavirus Vaccine Trials

Two drug companies that are leading the race to develop coronavirus vaccines bowed to public pressure on Thursday, abandoning their traditional secrecy and releasing comprehensive road maps of how they are evaluating their vaccines.

The companies, Moderna and Pfizer, revealed details about how participants are being selected and monitored, the conditions under which the trials could be stopped early if there were problems, and the evidence researchers will use to determine whether people who got the vaccines were protected from Covid-19.

Moderna’s study will involve 30,000 participants, and Pfizer’s 44,000.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Research
howdy folks